Literature DB >> 18592821

Availability of the epinephrine autoinjector at school in children with peanut allergy.

Moshe Ben-Shoshan1, Rhoda Kagan, Marie-Noël Primeau, Reza Alizadehfar, Nina Verreault, Joyce W Yu, Nathalie Nicolas, Lawrence Joseph, Elizabeth Turnbull, Claire Dufresne, Yvan St Pierre, Ann Clarke.   

Abstract

BACKGROUND: Peanut allergy accounts for most severe food-related allergic reactions, and accidental exposures are frequent. Delayed administration of epinephrine and the allergic individual's failure to personally carry epinephrine contribute to fatal outcomes.
OBJECTIVES: To describe epinephrine autoinjector availability at school and to determine factors that might affect autoinjector availability in children allergic to peanut.
METHODS: Two hundred seventy-one children with peanut allergy living in Quebec were queried about their autoinjector. Logistic regression models were used to select factors associated with device availability.
RESULTS: Four of 271 children diagnosed as having peanut allergy were not prescribed autoinjectors. Forty-eight percent of the children did not carry the autoinjector with them at school. In 78.0% of those, the autoinjector was located in the nurse's or another school office, which was staffed by a full-time nurse only in 18.5%. Of all the respondents, those administered epinephrine for a previous reaction (odds ratio [OR], 2.7; 95% confidence interval [CI], 1.3-5.7), older children (OR, 1.1; 95% CI, 1.0-1.2), and those living only with their mother (OR, 3.4; 95% CI, 1.0-11.0) were more likely to carry the autoinjector with them at school. Of children 7 years or older, those who experienced a severe reaction were more likely to carry their autoinjector (OR, 3.3; 95% CI, 1.4-8.1).
CONCLUSIONS: Almost 50% of children allergic to peanut might experience a delay in anaphylaxis treatment due to limited access to their device. More education is required regarding the importance of a readily available autoinjector.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18592821     DOI: 10.1016/S1081-1206(10)60056-7

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  13 in total

Review 1.  Managing food allergies in schools.

Authors:  Jay M Portnoy; Jodi Shroba
Journal:  Curr Allergy Asthma Rep       Date:  2014-10       Impact factor: 4.806

2.  Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel.

Authors:  Joshua A Boyce; Amal Assa'ad; A Wesley Burks; Stacie M Jones; Hugh A Sampson; Robert A Wood; Marshall Plaut; Susan F Cooper; Matthew J Fenton; S Hasan Arshad; Sami L Bahna; Lisa A Beck; Carol Byrd-Bredbenner; Carlos A Camargo; Lawrence Eichenfield; Glenn T Furuta; Jon M Hanifin; Carol Jones; Monica Kraft; Bruce D Levy; Phil Lieberman; Stefano Luccioli; Kathleen M McCall; Lynda C Schneider; Ronald A Simon; F Estelle R Simons; Stephen J Teach; Barbara P Yawn; Julie M Schwaninger
Journal:  J Allergy Clin Immunol       Date:  2010-12       Impact factor: 10.793

3.  World allergy organization guidelines for the assessment and management of anaphylaxis.

Authors:  F Estelle R Simons; Ledit R F Ardusso; M Beatrice Bilò; Yehia M El-Gamal; Dennis K Ledford; Johannes Ring; Mario Sanchez-Borges; Gian Enrico Senna; Aziz Sheikh; Bernard Y Thong
Journal:  World Allergy Organ J       Date:  2011-02-23       Impact factor: 4.084

4.  Loss-of-function variants in the filaggrin gene are a significant risk factor for peanut allergy.

Authors:  Sara J Brown; Yuka Asai; Heather J Cordell; Linda E Campbell; Yiwei Zhao; Haihui Liao; Kate Northstone; John Henderson; Reza Alizadehfar; Moshe Ben-Shoshan; Kenneth Morgan; Graham Roberts; Laury J N Masthoff; Suzanne G M A Pasmans; Peter C van den Akker; Cisca Wijmenga; Jonathan O'B Hourihane; Colin N A Palmer; Gideon Lack; Ann Clarke; Peter R Hull; Alan D Irvine; W H Irwin McLean
Journal:  J Allergy Clin Immunol       Date:  2011-03       Impact factor: 10.793

5.  Accidental exposures to peanut in a large cohort of Canadian children with peanut allergy.

Authors:  Sabrine Cherkaoui; Moshe Ben-Shoshan; Reza Alizadehfar; Yuka Asai; Edmond Chan; Stephen Cheuk; Greg Shand; Yvan St-Pierre; Laurie Harada; Mary Allen; Ann Clarke
Journal:  Clin Transl Allergy       Date:  2015-04-02       Impact factor: 5.871

6.  Epinephrine for anaphylaxis: underutilized and unavailable.

Authors:  Larissa S Dudley; Madonna I Mansour; Mark A Merlin
Journal:  West J Emerg Med       Date:  2015-04-06

7.  Administration of the adrenaline auto-injector at the nursery/kindergarten/school in Western Japan.

Authors:  Seigo Korematsu; Michiko Fujitaka; Mika Ogata; Masafumi Zaitsu; Chikako Motomura; Kazuyo Kuzume; Yuchiro Toku; Masanori Ikeda; Hiroshi Odajima
Journal:  Asia Pac Allergy       Date:  2017-01-26

Review 8.  Autoinjector device for rapid administration of drugs and antidotes in emergency situations and in mass casualty management.

Authors:  Rajagopalan Vijayaraghavan
Journal:  J Int Med Res       Date:  2020-05       Impact factor: 1.671

Review 9.  Adrenaline auto-injectors for the treatment of anaphylaxis with and without cardiovascular collapse in the community.

Authors:  Aziz Sheikh; F Estelle R Simons; Victoria Barbour; Allison Worth
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

10.  Exploring low-income families' financial barriers to food allergy management and treatment.

Authors:  Leia M Minaker; Susan J Elliott; Ann Clarke
Journal:  J Allergy (Cairo)       Date:  2014-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.